Abstract:Background It is well established that both cerebral hypoperfusion/stroke and type 2 diabetes are risk factors for Alzheimer's disease (AD). Recently, the molecular link between ischemia/hypoxia and amyloid precursor protein (APP) processing has begun to be established. However, the role of the key common denominator, namely nitric oxide (NO), in AD is largely unknown. In this study, we investigated redox regulation of BACE1, the rate-limiting enzyme responsible for the β-cleavage of APP to Aβ peptides. Results Herein, we studied events such as S-nitrosylation, a covalent modification of cysteine residues by NO, and H 2 O 2 -mediated oxidation. We found that NO and H 2 O 2 differentially modulate BACE1 expression and enzymatic activity: NO at low concentrations (<100 nM) suppresses BACE1 transcription as well as its enzymatic activity while at higher levels (0.1-100 μM) NO induces S-nitrosylation of BACE1 which inactivates the enzyme without altering its expression. Moreover, the suppressive effect on BACE1 transcription is mediated by the NO/cGMP-PKG signaling, likely through activated PGC-1α. H 2 O 2 (1-10 μM) induces BACE1 expression via transcriptional activation, resulting in increased enzymatic activity. The differential effects of NO and H 2 O 2 on BACE1 expression and activity are also reflected in their opposing effects on Aβ generation in cultured neurons in a dose-dependent manner. Furthermore, we found that BACE1 is highly S-nitrosylated in normal aging brains while S-nitrosylation is markedly reduced in AD brains. Conclusion This study demonstrates for the first time that BACE1 is highly modified by NO via multiple mechanisms: low and high levels of NO suppress BACE1 via transcriptional and post translational regulation, in contrast with the upregulation of BACE1 by H 2 O 2 -mediated oxidation. These novel NO-mediated regulatory mechanisms likely protect BACE1 from being further oxidized by excessive oxidative stress, as from H 2 O 2 and peroxynitrite which are known to upregulate BACE1 and activate the enzyme, resulting in excessive cleavage of APP and Aβ generation; they likely represent the crucial house-keeping mechanism for BACE1 expression/activation under physiological conditions.

BACE2 Degradation is Mediated by Both the Proteasome and Lysosome Pathways

Lys203 and Lys382 Are Essential for the Proteasomal Degradation of BACE1

Distinct Transcriptional Regulation and Function of the Human Bace2 and Bace1 Genes

Degradation of BACE by the Ubiquitin‐proteasome Pathway

BACE1 SUMOylation Increases Its Stability and Escalates the Protease Activity in Alzheimer's Disease.

Alzheimer's Β-Secretase (BACE1) Regulates the Camp/pka/creb Pathway Independently of Β-Amyloid.

BACE1 and BACE2 enzymatic activities in Alzheimer's disease.

BACE1 Gene Expression and Protein Degradation.

BACE2, As a Novel APP Θ‐secretase, is Not Responsible for the Pathogenesis of Alzheimer's Disease in Down Syndrome

Regulation Of Ss-Site App-Cleaving Enzyme 1 Gene Expression And Its Role In Alzheimer'S Disease

Control of App Processing and A Beta Generation Level by Bace1 Enzymatic Activity and Transcription

Progress in the Development of Nonpeptidomimetic BACE 1 Inhibitors for Alzheimers Disease

The Transmembrane Domain of the Alzheimer's Beta-Secretase (BACE1) Determines Its Late Golgi Localization and Access to Beta -Amyloid Precursor Protein (APP) Substrate.

O4‐02‐01: A Novel Role of Beta‐secretase1 (BACE1) in the Pathogenesis of Cerebral Amyloid Angiopathy (CAA)

Receptor Tyrosine Kinases Positively Regulate BACE Activity and Amyloid-β Production Through Enhancing BACE Internalization

Mitochondrial Respiratory Inhibition and Oxidative Stress Elevate Β-Secretase (BACE1) Proteins and Activity in Vivo in the Rat Retina

Differential Regulation of BACE1 Expression by Oxidative and Nitrosative Signals

A Novel Role Of Beta-Secretase 1 (Bace1) In The Pathogenesis Of Cerebral Amyloid Angiopathy (Caa)

BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time

BACE2 Variant Identified from HSCR Patient Causes AD-like Phenotypes in Hpsc-Derived Brain Organoids

BACE1-AS Prevents BACE1 Mrna Degradation Through the Sequestration of BACE1-targeting Mirnas.